Prevalence and comorbidities in adults with psoriasis compared to atopic eczema

Journal of the European Academy of Dermatology and Venereology

Volumn 31, Issue 1, 2017, Pages 151-157

  Radtke, M A ^a   Schafer I ^a   Glaeske, G ^b   Jacobi, A ^a   Augustin, M ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF BREMEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALLERGIC RHINITIS; ALOPECIA AREATA; ARTICLE; ASTHMA; ATOPIC DERMATITIS; ATTENTION DEFICIT DISORDER; COMORBIDITY; CONTROLLED STUDY; CROHN DISEASE; DEPRESSION; DIABETES MELLITUS; DISEASE SEVERITY; EVALUATION STUDY; GROUPS BY AGE; HEALTH INSURANCE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IMPETIGO; IRIDOCYCLITIS; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; OBESITY; PREVALENCE; PRIORITY JOURNAL; PSORIASIS; RHEUMATOID ARTHRITIS; ULCERATIVE COLITIS; VITILIGO; COMPARATIVE STUDY; DERMATITIS, ATOPIC; ECZEMA;

ADULT; DERMATITIS, ATOPIC; ECZEMA; HUMANS; PREVALENCE; PSORIASIS;

EID: 84981346604     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/jdv.13813     Document Type: Article

References (56)

1. Schaefer T. Epidemiology of psoriasis. Review and the German perspective. Dermatology 2006; 212: 327–337.
2. Thomsen SF. Atopic dermatitis: natural history, diagnosis, and treatment. ISRN Allergy 2014; 2014: 354250.
3. Augustin M, Glaeske G, Radtke MA, Christophers E, Reich K, Schäfer I. Epidemiology and comorbidity of psoriasis in children. Br J Dermatol 2010; 162: 633–636.
4. Suárez-Farinas M, Li K, Fuentes-Duculan J, Hayden K, Brodmerkel CD, Krueger JG. Expanding the psoriasis disease profile: interrogation of the skin and serum of patients with moderate to severe psoriasis. J Invest Dermatol 2012; 312: 2552–2564.
5. Quaranta M, Knapp B, Garzorz N et al. Intraindividual genome expression analysis reveals a specific molecular signature of psoriasis and eczema. Sci Transl Med 2014; 6: 244ra90.
6. Wakkee M, Nijsten T. Comorbidities in dermatology. Dermatol Clin 2009; 27: 137–147.
7. Montaudié H, Albert-Sabonnadière C, Acquacalda E et al. Impact of systemic treatment of psoriasis on inflammatory parameters and markers of comorbidities and cardiovascular risk: results of a prospective longitudinal observational study. J Eur Acad Dermatol Venereol 2014; 28: 1186–1191.
8. Boehncke WH, Schön MP. Psoriasis. Lancet 2015; 386: 983–994.
9. Augustin M, Reich K, Glaeske G, Schaefer I, Radtke MA. Co-morbidity and age-related prevalence of psoriasis: analysis of health insurance data in Germany. Acta Derm Venereol 2010; 90: 147–151.
10. Wu Y, Mills D, Bala M. Psoriasis: cardiovascular risk factors and other disease comorbidities. J Drugs Dermatol 2008; 7: 373–377.
11. Al-Mutairi N, Al-Farag S, Al-Mutairi A, Al-Shiltawy M. Comorbidities associated with psoriasis: an experience from the Middle East. J Dermatol 2010; 37: 146–155.
12. Khalid U, Ahlehoff O, Gislason GH et al. Psoriasis and risk of heart failure: a nationwide cohort study. Eur J Heart Fail 2014; 16: 743–748.
13. Ogdie A, Yu Y, Haynes K et al. Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study. Ann Rheum Dis 2015; 74: 326–332.
14. Egeberg A, Khalid U, Gislason GH, Mallbris L, Skov L, Hansen PR. Impact of depression on risk of myocardial infarction, stroke and cardiovascular death in patients with psoriasis: a Danish Nationwide Study. Acta Derm Venereol 2016; 96: 218–221.
15. Li X, Kong L, Li F, Chen C et al. Association between Psoriasis and Chronic Obstructive Pulmonary Disease: a Systematic Review and Meta-analysis. PLoS ONE 2015; 10: e0145221.
16. Silverberg J, Garg N, Silverberg NB. New developments in comorbidities of atopic dermatitis. Cutis 2014; 93: 222–224.
17. Su VY, Chen TJ, Yeh CM et al. Atopic dermatitis and risk of ischaemic stroke: a nationwide population-based study. Ann Med 2014; 46: 84–89.
18. Liao TC, Lien YT, Wang S, Huang SL, Chen CY. Comorbidity of atopic disorders with autism spectrum disorder and attention deficit/hyperactivity disorder. J Pediatr 2016; 171: 248–255.
19. Schmitt J, Schwarz K, Baurecht H et al. Atopic dermatitis is associated with an increased risk for rheumatoid arthritis and inflammatory bowel disease, and a decreased risk for type 1 diabetes. J Allergy Clin Immunol 2016; 137: 130–136.
20. Schmitt J, Weidinger S. Alternative models of comorbidity: a framework for the interpretation of epidemiological association studies. J Invest Dermatol 2014; 134: 303–307.
21. Sorensen HT, Sabroe S, Olsen J. A framework for evaluation of secondary data sources for epidemiological research. Int J Epidemiol 1996; 25: 435–442.
22. Schaefer I, Zimmer L, Rustenbach SJ, Augustin M. Prevalence of skin diseases in a cohort of 48 665 employees in Germany. Dermatology 2008; 217: 169–172.
23. Wüthrich B. Clinical aspects, epidemiology, and prognosis of atopic dermatitis. Ann Allergy Asthma Immunol 1999; 83: 464–470.
24. Garmhausen D, Hagemann T, Bieber T et al. Characterization of different courses of atopic dermatitis in adolescent and adult patients. Allergy 2013; 68: 498–506.
25. Figueroa-Munoz JI, Chinn S, Rona RJ. Association between obesity and asthma in 4–11 year old children in the UK. Thorax 2001; 56: 133–137.
26. Gennuso J, Epstein LH, Paluch RA, Cerny F. The relationship between asthma and obesity in urban minority children and adolescents. Arch Pediatr Adolesc Med 1998; 152: 1197–1200.
27. Kaplan BA, Brush G, Mascie-Taylor CG. The relationship of childhood asthma and wheezy bronchitis with height, weight and body mass index. Hum Biol 1987; 59: 921–931.
28. von Kries R, Hermann M, Grunert VP, von Mutius E. Is obesity a risk factor for childhood asthma? Allergy 2001; 56: 318–322.
29. von Mutius E, Schwartz J, Neas LM, Dockery D, Weiss ST. Relation of body mass index to asthma and atopy in children: the National Health and Nutrition Examination Study III. Thorax 2001; 56: 835–838.
30. Luder E, Melnik TA, DiMaio M. Association of being overweight with greater asthma symptoms in inner city black and Hispanic children. J Pediatr 1998; 132: 699–703.
31. Mai XM, Nilsson L, Axelson O et al. High body mass index, asthma and allergy in Swedish schoolchildren participating in the International Study of Asthma and Allergies in Childhood: Phase II. Acta Paediatr 2003; 92: 1144–1148.
32. Tai A, Volkmer R, Burton A. Association between asthma symptoms and obesity in preschool (4–5 year old) children. J Asthma 2009; 46: 362–365.
33. Schachter LM, Peat JK, Salome CM. Asthma and atopy in overweight children. Thorax 2003; 58: 1031–1035.
34. Visness CM, London SJ, Daniels JL et al. Association of obesity with IgE levels and allergy symptoms in children and adolescents: results from the National Health and Nutrition Examination Survey 2005–2006. J Allergy Clin Immunol 2009; 123: 1163–1169, 9e1–4.
35. Murray CS, Canoy D, Buchan I, Woodcock A, Simpson A, Custovic A. Body mass index in young children and allergic disease: gender differences in a longitudinal study. Clin Exp Allergy 2011; 41: 78–85.
36. Suarez-Varela MM, Alvarez LG, Kogan MD et al. Diet and prevalence of atopic eczema in 6 to 7-year-old schoolchildren in Spain: ISAAC phase III. J Investig Allergol Clin Immunol 2010; 20: 469–475.
37. Kusunoki T, Morimoto T, Nishikomori R et al. Obesity and the prevalence of allergic diseases in schoolchildren. Pediatr Allergy Immunol 2008; 19: 527–534.
38. Violante R, del Rio Navarro BE, Berber A, Ramírez Chanona N, Baeza Bacab M, Sienra Monge JJ. Obesity risk factors in the ISAAC (International Study of Asthma and Allergies in Childhood) in Mexico City. Rev Alerg Mex 2005; 52: 141–145.
39. Vlaski E, Stavric K, Isjanovska R, Seckova L, Kimovska M. Overweight hypothesis in asthma and eczema in young adolescents. Allergol Immunopathol (Madr) 2006; 34: 199–205.
40. Silverberg JI, Silverberg NB, Lee-Wong M. Association between atopic dermatitis and obesity in adulthood. Br J Dermatol 2012; 166: 498–504.
41. Deckert S, Schmitt J. Nonallergic comorbidities of atopic dermatitis. Hautarzt 2015; 66: 103–107.
42. Chen MH, Su TP, Chen YS et al. Is atopy in early childhood a risk factor for ADHD and ASD? a longitudinal study. J Psychosom Res 2014; 77: 316–321.
43. Schmitt J, Buske-Kirschbaum A, Roessner V. Is atopic disease a risk factor for attention-deficit/hyperactivity disorder? A systematic review J Allerg Allergy 2010; 65: 1506–1524.
44. Schmitt J. Health services research the example of atopic dermatitis. Hautarzt 2001; 62: 178–188.
45. Radtke MA, Mrowietz U, Feuerhahn J et al. Early detection of comorbidity in psoriasis: recommendations of the National Conference on Healthcare in Psoriasis. J Dtsch Dermatol Ges 2015; 13: 674–690.
46. Steyers CM, Miller FJ. Endothelial dysfunction in chronic inflammatory diseases. Int J Mol Sci 2014; 15: 11324–11349.
47. Villani AP, Rouzaud M, Sevrain M et al. Prevalence of undiagnosed psoriatic arthritis among psoriasis patients: systematic review and meta-analysis. J Am Acad Dermatol 2015; 73: 242–248.
48. D'Epiro S, Marocco C, Salvi M et al. Psoriasis and bone mineral density: implications for long-term patients. J Dermatol 2014; 41: 783–787.
49. Zhu TY, Griffith JF, Qin L et al. Density, structure, and strength of the distal radius in patients with psoriatic arthritis: the role of inflammation and cardiovascular risk factors. Osteoporos Int 2015; 26: 261–272.
50. Iskandar IY, Ashcroft DM, Warren RB et al. Demographics and disease characteristics of patients with psoriasis enrolled in the British Association of Dermatologists Biologic Interventions Register. Br J Dermatol 2015; 173: 510–518.
51. Gelfand JM, Troxel AB, Lewis JD et al. The risk of mortality in patients with psoriasis: results from a population-based study. Arch Dermatol 2007; 143: 1493–1499.
52. Wakkee M, Herings RM, Nijsten T. Psoriasis may not be an independent risk factor for acute ischemic heart disease hospitalizations: results of a large population-based Dutch cohort. J Invest Dermatol 2010; 130: 962–967.
53. Stern RS, Huibregtse A. Very severe psoriasis is associated with increased noncardiovascular mortality but not with increased cardiovascular risk. J Invest Dermatol 2011; 131: 1159–1166.
54. Ryan C, Korman NJ, Gelfand JM et al. Research gaps in psoriasis: opportunities for future studies. J Am Acad Dermatol 2014; 70: 146–167.
55. Parisi R, Rutter MK, Lunt M et al. Identification and Management of Psoriasis Associated ComorbidiTy (IMPACT) project team. Psoriasis and the Risk of Major Cardiovascular Events: cohort Study Using the Clinical Practice Research Datalink. J Invest Dermatol. 2015; 135: 2189–2197.
56. Feldman SR, Zhao Y, Shi L, Tran MH. Economic and comorbidity burden among patients with moderate-to-severe psoriasis. J Manag Care Spec Pharm 2015; 21: 874–888.